Dongsung biopharmaceutical with 60 years of history provides customer-oriented total services and future-oriented marketing which covers cosmetics and finished medicine.
We're tracking Dongsung Bio Pharmaceutical Co., Ltd.'s market expansion
How Dongsung Bio Pharmaceutical Co., Ltd.'s international expansion compares to its competitors
Dongsung Bio Pharmaceutical Co., Ltd.YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Dongsung Bio Pharmaceutical Co., Ltd.You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Dongsung Pharma's anti-dandruff treatment 'Vigasol' is experiencing a shortage due to high demand. The product saw 28% growth in 2024 compared to 2023.
Multiple Korean companies reported Q2 2025 financial results, including Kiwoom Securities, SOOP, GS E&C, and others. Several firms announced investments, contracts, and corporate actions.
Dongsung Pharma denies 17.7 billion won embezzlement allegations, calling them baseless. The company plans legal action against these claims.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Dongsung Bio Pharmaceutical Co., Ltd.'s business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
